Skip to main content
. 2014 Oct 8;100(6):1541–1550. doi: 10.3945/ajcn.114.087379

TABLE 1.

Baseline anthropometric data for Zambian children (n = 140) enrolled in a bioefficacy trial investigating biofortified orange maize by randomized treatment groups1

VA− (n = 47) Orange (n = 46) VA+ (n = 47) P value2
Age,3 mo 69.0 (65.2, 72.8)4 69.0 (66.5, 71.5) 71.0 (67.7, 74.3) 0.99
Weight,3 kg 17.1 (15.9, 18.3) 17.4 (16.4, 18.3) 16.8 (16.3, 17.3) 0.89
Height, cm 107.3 ± 6.35 108.1 ± 5.3 107.4 ± 4.7 0.75
Hemoglobin, g/L 114 ± 13 117 ± 12 118 ± 9 0.23
Sex, % male 51.1 47.8 61.7 0.67
Malaria, % 17.0 8.7 8.5 0.35
BMI,3 kg/m2 14.9 (14.6, 15.2) 14.7 (14.5, 14.9) 14.6 (14.4, 14.8) 0.34
Height-for-age z score −1.53 ± 1.18 −1.40 ± 0.91 −1.53 ± 0.88 0.76
Weight-for-age z score −1.18 ± 0.93 −1.17 ± 0.79 −1.31 ± 0.81 0.64
BMI-for-age z score3 −0.33 (−0.57, −0.09) −0.48 (−0.67, −0.29) −0.52 (−0.69, −0.35) 0.33
1

Baseline data were taken during recruitment day, which included the baseline blood draw 1 for 13C-natural abundance. The VA– group received white maize with placebo oil, the orange group received orange maize with placebo oil, and the VA+ group received white maize with VA in oil (400 μg retinol activity equivalents/d in 214 μL). VA, vitamin A.

2

P values were determined by testing the null hypothesis that each variable is equal among treatment groups by using ANOVA or χ2 test.

3

Indicates nonnormally distributed residuals; P value reflects nonparametric analysis.

4

Median; 95% CI in parentheses (all such values).

5

Mean ± SD (all such values).